Creative Planning’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,762
Closed -$93.8K 3897
2025
Q3
$93.8K Buy
17,762
+3,452
+24% +$21.9K ﹤0.01% 3679
2025
Q2
$81.3K Buy
14,310
+4,305
+43% +$24.5K ﹤0.01% 3457
2025
Q1
$47.6K Buy
+10,005
New +$54.4K ﹤0.01% 3350
2024
Q3
Sell
-10,043
Closed -$42.6K 3188
2024
Q2
$42.6K Sell
10,043
-4,962
-33% -$25.3K ﹤0.01% 2937
2024
Q1
$109K Buy
+15,005
New +$95.1K ﹤0.01% 2694
2023
Q4
Sell
-14,005
Closed -$59K 2747
2023
Q3
$59K Buy
+14,005
New +$53K ﹤0.01% 2464
2023
Q2
Sell
-22,011
Closed -$62.1K 2646
2023
Q1
$62.1K Buy
22,011
+2,000
+10% +$5.23K ﹤0.01% 2315
2022
Q4
$61.6K Buy
+20,011
New +$74.8K ﹤0.01% 2205
2018
Q4
Sell
-2,735
Closed -$875K 1942
2018
Q3
$875K Buy
+2,735
New +$970K ﹤0.01% 817
2017
Q3
Sell
-86
Closed -$14K 1887
2017
Q2
$14K Hold
86
﹤0.01% 3398
2017
Q1
$11K Hold
86
﹤0.01% 3516
2016
Q4
$10K Sell
86
-12
-12% -$1.88K ﹤0.01% 3533
2016
Q3
$15K Buy
98
+2
+2% +$196 ﹤0.01% 3228
2016
Q2
$6K Hold
96
﹤0.01% 3515
2016
Q1
$6K Hold
96
﹤0.01% 3470
2015
Q4
$8K Buy
96
+80
+500% +$8.02K ﹤0.01% 3399
2015
Q3
$2K Buy
+16
New +$2.12K ﹤0.01% 3908
2015
Q2
Sell
-16
Closed -$1K 1113
2015
Q1
$1K Hold
16
﹤0.01% 3992
2014
Q4
$1K Buy
+16
New +$1.44K ﹤0.01% 3938

Other funds holding ABEO

Creative Planning's ABEO Position: Q4 2025 in Review

Creative Planning sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 17,762 shares — an estimated $93.8K sold.

Creative Planning first reported a position in ABEO in Q4 2014 and held it in 19 quarters. The position peaked at $875K in Q3 2018. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Creative Planning reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Creative Planning sold 17,762 Abeona Therapeutics shares in Q4 2025, an estimated $93.8K.
  • Creative Planning first reported a position in Abeona Therapeutics in Q4 2014 and held it in 19 quarters.
  • Creative Planning's Abeona Therapeutics position peaked at $875K in Q3 2018.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Creative Planning's 13F filing for Q4 2025, filed 17 Feb 2026.